These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 28554)

  • 21. Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism.
    Stolk JM; Vantini G; Perry BD; Guchhait RB; U'Prichard DC
    J Pharmacol Exp Ther; 1984 Sep; 230(3):577-86. PubMed ID: 6147403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and regulation of tyrosine hydroxylase mRNA in catecholaminergic terminal fields: possible axonal compartmentalization.
    Melia KR; Trembleau A; Oddi R; Sanna PP; Bloom FE
    Exp Neurol; 1994 Dec; 130(2):394-406. PubMed ID: 7532593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine hydroxylase activity in the sympathoadrenal system under basal and stressful conditions: effect of 6-hydroxydopamine.
    Fluharty SJ; Rabow LE; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1985 Nov; 235(2):354-60. PubMed ID: 2865349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress.
    Fluharty SJ; Snyder GL; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1985 Apr; 233(1):32-8. PubMed ID: 2858582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial damage to the noradrenergic bundle increases tyrosine hydroxylase activity in noradrenergic terminals of hippocampus but not cerebellum.
    Fluharty SJ; Stricker EM; Zigmond MJ
    Brain Res; 1984 Dec; 324(2):390-3. PubMed ID: 6152190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1972 Feb; 44(2):210-22. PubMed ID: 4148915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in brain norepinephrine content in mice following neonatal 6-hydroxydopamine.
    Lovell KL
    Brain Res Bull; 1981 Jul; 7(1):41-4. PubMed ID: 7272787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine.
    Konkol RJ; Bendeich EG; Breese GR
    Brain Res; 1978 Jan; 140(1):125-35. PubMed ID: 626876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reserpine effect on the axonal transport of dopamine-beta-hydroxylase and tyrosine hydroxylase in rat brain.
    Levin BE
    Exp Neurol; 1981 Apr; 72(1):99-112. PubMed ID: 6162666
    [No Abstract]   [Full Text] [Related]  

  • 30. Altered responsiveness of adenosine 3',5'-monophosphate-generating systems in brain slices from adult rats after neonatal treatment with 6-hydroxydopamine.
    Dismukes RK; Daly JW
    Exp Neurol; 1975 Oct; 49(1 Pt 1):150-60. PubMed ID: 171170
    [No Abstract]   [Full Text] [Related]  

  • 31. Tyrosine hydroxylase activity in rat brain regions after chronic treatment with +/--propranolol.
    Peters DA; Mazurkiewicz-Kwilecki IM
    J Pharm Pharmacol; 1975 Sep; 27(9):671-6. PubMed ID: 241811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
    Quik M; Sourkes TL
    J Neurochem; 1977 Jan; 28(1):137-47. PubMed ID: 13151
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural and neurochemical effects in mouse cerebellum following neonatal methylazoxymethanol and 6-hydroxydopamine treatment.
    Luthman J; Eriksdotter-Nilsson M; Jonsson G
    Int J Dev Neurosci; 1990; 8(1):107-18. PubMed ID: 1967503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular and perisynaptic distribution of rat brain aldehyde dehydrogenase activity.
    Koivula T; Turner AJ; Huttunen M; Koivusalo M
    J Neurochem; 1981 Jun; 36(6):1893-7. PubMed ID: 6113270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. III. Histochemical fluorescence and radioautographic studies of the noradrenaline hyperinnervation in the pons.
    Arluison M; De La Manche IS; Adrien J; Hamon M; Laguzzi R; Bourgoin S
    Brain Res; 1980 Oct; 198(2):285-305. PubMed ID: 7407599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disappearance and recovery of catecholamine innervation in brain regions of adult goldfish following 6-hydroxydopamine treatment.
    Contestabile A; Friz T; Caravaggio MV
    Neurosci Lett; 1979 Oct; 14(2-3):333-7. PubMed ID: 530509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential changes of skin conductance activity in rats after intraventricular administration of 6-hydroxydopamine.
    Yamamoto K; Kaneko H
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(6):723-8. PubMed ID: 3101137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intraventricular administration of noradrenaline and dopamine on the levels of corticosterone in rats and denervation hypersensitivity resulting from intraventricular administration of 6-hydroxydopamine.
    Kawa A; Taniguchi Y; Mizuguchi K; Ryu S; Ariyama T; Kamisaki T; Koreeda F; Kanehisa T
    Life Sci; 1978 Sep; 23(9):991-7. PubMed ID: 703530
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of 6-hydroxydopamine on dopa and tyrosine entry into brain.
    Snodgrass SR
    Biochem Pharmacol; 1976 Jul; 25(14):1675-9. PubMed ID: 8048
    [No Abstract]   [Full Text] [Related]  

  • 40. Free amino acids in cytosol of rat brain after intraventricular administration of 5,6-dihydroxytryptamine and 6-hydroxydopamine.
    Konecki J; Gabrys J; Brus R; Szkilnik R; Shani J
    Z Naturforsch C J Biosci; 1987 May; 42(5):637-40. PubMed ID: 2955598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.